Marcadores biológicos de inflamación y control del tratamiento hipolipemiante

The formation of atherosclerotic lesions is characterized by a chronic inflammatory response. In the last few years, the search for biological markers of inflammation related to cardiovascular disease has given rise to the discovery of several proteins that could serve as independent markers of cardiovascular risk. Using a simple analysis, we can characterize the circulating level of these markers of inflammation, as well as their possible modulation through pharmacological treatment. In the present article, we analyze several markers of inflammation such as C-reactive protein, CD40 ligand, adhesion molecules and chemokines, as well as their possible modulation through therapeutic interventions with lipid-lowering drugs. Moreover, in the future, new technologies will allow us to discover new markers, or sets of markers, that could indicate the direction to be taken in the prevention and treatment of cardiovascular disease.